Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Black Cohosh and Reduced Vulvovaginal Atrophy Symptom

Doses used in studies

mg/day: 40 (median 40, IQR 40–40) — 1 study

Time to effect

Median: 5.4 months · IQR 5.4 months–5.4 months · Range 5.4 months–5.4 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
Similarly, evidence on the safety of black cohosh was inconclusive, owing to poor reporting.
from: Black cohosh (Cimicifuga spp.) for menopausal symptoms.

1 of 1 paper

Black cohosh (Cimicifuga spp.) for menopausal symptoms.
- 2012-09-12
- Meta-Analysis · n = 2,027
- The Cochrane database of systematic reviews 2012(10)
- - Matthew J Leach
  - Vivienne Moore
- PubMed: 22972105
- DOI: 10.1002/14651858.cd007244.pub2
4 Insights on
- Reduced Vulvovaginal Atrophy Symptom
- High evidence
- Clinical
There were insufficient data to pool results for health-related quality of life, sexuality, bone health, vulvovaginal atrophic symptoms and night sweats.
Effect
Neutral
Effect size
Small
Significant
No
Dose
40 mg/day (median)